Pharmaceutical Technology, November 2014 Issue (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-11-02-2014
Volume 38
Issue 11

Click the title above to open the Pharmaceutical Technology November 2014 issue in an interactive PDF format.

External Link - PharmTech_NA_Nov2014.pdf

Articles in this issue
Wechsler_Jill-859697-1417772624646.jpg
New Era for Generic Drugs
rpeters-headshot-2013-859916-1417773874906.jpg
Hype vs. Health
Advances in Large-Scale Heterocyclic Synthesis
Advances in Large-Scale Heterocyclic Synthesis
EMD-859927-1417773857962.jpg
Steritest Symbio Pumps Increase Productivity
Milmo_Sean-859269-1417773629909.jpg
Tackling Drug Shortages
Injecting Highly Viscous Drugs
Injecting Highly Viscous Drugs
C2C-859926-1417773863930.jpg
Cleanroom Filtration System Minimizes Costs
Using Flow Sensors to Monitor Process System Health
Using Flow Sensors to Monitor Process System Health
Parenterals, Particulates, and Quality by Design
Parenterals, Particulates, and Quality by Design
GMPs for Small-Molecule Drugs in Early Development: Workshop Summary-Part VI
GMPs for Small-Molecule Drugs in Early Development: Workshop Summary-Part VI
Germany Post AMNOG: Insights for BioPharma
Germany Post AMNOG: Insights for BioPharma
main-859773-1417772512251.jpg
Continuous Solid-Dosage Manufacturing Platform Nears Prototype Installation
DoE Provides Benefits, but Preparation Is Necessary
DoE Provides Benefits, but Preparation Is Necessary
sidebar-figure-859869-1417773985936.jpg
Measuring syringe plunger force using a texture analyzer instrument
A Robust CAPA System for a Global Supply Chain
A Robust CAPA System for a Global Supply Chain
Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Related Content
TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025

Patrick Lavery
March 17th 2025
Article

This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.

Drug Solutions Podcast: Forecasting Pharma’s Future

Drug Solutions Podcast: Forecasting Pharma’s Future

Felicity Thomas
January 31st 2025
Podcast

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Vetter to Expand German Warehouse, Doubling Cool Storage Capacity

Patrick Lavery
March 14th 2025
Article

The company plans to add 16,000 pallet spaces to the 13,000 it already has on site, making for a total of 68,000 pallet spaces covering various temperature requirements.

Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

CordenPharma and Viking Therapeutics to Partner for Integrated Supply of GLP-1s

Patrick Lavery
March 13th 2025
Article

The multi-year strategic partnership is intended to support commercial demand of Viking Therapeutics’ GLP-1 candidate, VK2735.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

Sun Pharma Agrees to Acquire Checkpoint Therapeutics

Patrick Lavery
March 12th 2025
Article

The transaction includes Unloxcyt (cosibelimab-ipdl), which was approved by FDA in December 2024 for treatment of adults with cutaneous squamous cell carcinoma (cSCC).